StockNews.com initiated coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note published on Wednesday morning. The firm issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.00 on Wednesday. The firm’s 50-day moving average price is $0.04 and its two-hundred day moving average price is $0.51. Ampio Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $7.47. The stock has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 2.21.
About Ampio Pharmaceuticals
Further Reading
- Five stocks we like better than Ampio Pharmaceuticals
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- When to Sell a Stock for Profit or Loss
- Introduction to Fibonacci Retracement Levels
- What is the Nikkei 225 index?
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
